Tonix Pharmaceuticals Reports Second Quarter 2014 Financial Results
August 08, 2014 16:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Aug. 8, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced its financial results for the quarter ended June 30, 2014.
"In the second quarter, we...
Tonix Pharmaceuticals to Present at Two Investor Conferences in August
August 06, 2014 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company focused on common disorders of the central nervous system,...
Tonix Pharmaceuticals Announces Registered Direct Offering of $7.8 Million
July 11, 2014 08:20 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, July 11, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company focused on common disorders of the central nervous system, today...
Tonix Pharmaceuticals Joins Russell Microcap Index
June 30, 2014 12:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 30, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company focused on common disorders of the central nervous system, was...
Tonix Pharmaceuticals Appoints Ronald R. Notvest, Ph.D. as Senior Vice President of Commercial Planning and Development
June 26, 2014 08:30 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 26, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company focused on common disorders of the central nervous system, has...
Tonix Pharmaceuticals Receives IND Clearance From U.S. Food and Drug Administration for TNX-102 SL in Post-Traumatic Stress Disorder
June 10, 2014 08:30 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 10, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA)...
Tonix Appoints Gregory M. Sullivan, M.D. as Chief Medical Officer
June 03, 2014 09:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company, has appointed Gregory M. Sullivan, M.D. Chief Medical Officer, a...
Tonix Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference
May 29, 2014 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 29, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company, will present at the Jefferies 2014 Global Healthcare Conference...
Tonix Pharmaceuticals to Present at the LD Micro Invitational Conference
May 29, 2014 08:20 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 29, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company, will present at the 4th Annual LD Micro Invitational Conference...
Tonix Pharmaceuticals to be Added to the MSCI Global Micro Cap Index
May 28, 2014 14:26 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 28, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company, will be added to the Morgan Stanley Capital International (MSCI)...